These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 10456387
1. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro. Qu Q, Härkönen PL, Mönkkönen J, Väänänen HK. Bone; 1999 Aug; 25(2):211-5. PubMed ID: 10456387 [Abstract] [Full Text] [Related]
2. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Michael H, Härkönen PL, Väänänen HK, Hentunen TA. J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275 [Abstract] [Full Text] [Related]
3. Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures. Soma S, Matsumoto S, Takano-Yamamoto T. Arch Oral Biol; 1997 Mar; 42(3):205-11. PubMed ID: 9188990 [Abstract] [Full Text] [Related]
4. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts. Zhang F, Tanaka H, Kawato T, Kitami S, Nakai K, Motohashi M, Suzuki N, Wang CL, Ochiai K, Isokawa K, Maeno M. Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352 [Abstract] [Full Text] [Related]
5. Estrogen blocks parathyroid hormone-stimulated osteoclast-like cell formation in modulating differentiation of mouse marrow stromal cells in vitro. Liu BY, Wu PW, Hsu YT, Leu JS, Wang JT. J Formos Med Assoc; 2002 Jan; 101(1):24-33. PubMed ID: 11911034 [Abstract] [Full Text] [Related]
6. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts. Perez-Amodio S, Beertsen W, Everts V. J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568 [Abstract] [Full Text] [Related]
7. 17Beta-estradiol antagonizes effects of 1alpha,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures. Schiller C, Gruber R, Redlich K, Ho GM, Katzgraber F, Willheim M, Pietschmann P, Peterlik M. Endocrinology; 1997 Nov; 138(11):4567-71. PubMed ID: 9348179 [Abstract] [Full Text] [Related]
8. Effect of estrogen on the activity and growth of human osteoclasts in vitro. Chen FP, Wang KC, Huang JD. Taiwan J Obstet Gynecol; 2009 Dec; 48(4):350-5. PubMed ID: 20045755 [Abstract] [Full Text] [Related]
9. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity. Collin-Osdoby P, Oursler MJ, Rothe L, Webber D, Anderson F, Osdoby P. J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630 [Abstract] [Full Text] [Related]
10. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts. Grano M, Mori G, Minielli V, Cantatore FP, Colucci S, Zallone AZ. Biochem Biophys Res Commun; 2000 Apr 21; 270(3):1097-100. PubMed ID: 10772956 [Abstract] [Full Text] [Related]
11. Down-regulation of osteoclast differentiation by daidzein via caspase 3. Rassi CM, Lieberherr M, Chaumaz G, Pointillart A, Cournot G. J Bone Miner Res; 2002 Apr 21; 17(4):630-8. PubMed ID: 11918220 [Abstract] [Full Text] [Related]
12. Cellular and molecular effects of growth hormone and estrogen on human bone cells. Kassem M. APMIS Suppl; 1997 Apr 21; 71():1-30. PubMed ID: 9357492 [Abstract] [Full Text] [Related]
13. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures. Ramalho AC, Couttet P, Baudoin C, Morieux C, Graulet AM, de Vernejoul MC, Cohen-Solal ME. Eur Cytokine Netw; 2002 Apr 21; 13(1):39-45. PubMed ID: 11956019 [Abstract] [Full Text] [Related]
14. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. Tani-Ishii N, Tsunoda A, Teranaka T, Umemoto T. J Dent Res; 1999 Oct 21; 78(10):1617-23. PubMed ID: 10520966 [Abstract] [Full Text] [Related]
15. A novel culture system to generate osteoclasts and bone resorption using porcine bone marrow cells: role of M-CSF. Scheven BA, Milne JS, Robins SP. Biochem Biophys Res Commun; 1997 Feb 03; 231(1):231-5. PubMed ID: 9070255 [Abstract] [Full Text] [Related]
16. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W. Bone; 2006 Aug 03; 39(2):325-35. PubMed ID: 16580896 [Abstract] [Full Text] [Related]
17. The cellular actions of interleukin-11 on bone resorption in vitro. Hill PA, Tumber A, Papaioannou S, Meikle MC. Endocrinology; 1998 Apr 03; 139(4):1564-72. PubMed ID: 9528935 [Abstract] [Full Text] [Related]
18. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. J Exp Med; 2000 Jan 17; 191(2):275-86. PubMed ID: 10637272 [Abstract] [Full Text] [Related]
19. Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media. Costa-Rodrigues J, Teixeira CA, Sampaio P, Fernandes MH. J Cell Biochem; 2010 Jan 01; 109(1):205-16. PubMed ID: 19911374 [Abstract] [Full Text] [Related]
20. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Okazaki R, Toriumi M, Fukumoto S, Miyamoto M, Fujita T, Tanaka K, Takeuchi Y. Endocrinology; 1999 Nov 01; 140(11):5060-5. PubMed ID: 10537132 [Abstract] [Full Text] [Related] Page: [Next] [New Search]